Literature DB >> 18265883

Levetiracetam efficacy in idiopathic generalized epilepsy: long suspected and now confirmed in randomized clinical trials.

Bassel W Abou-Khalil.   

Abstract

Entities:  

Year:  2008        PMID： 18265883      PMCID： PMC2238649          DOI： 10.1111/j.1535-7511.2007.00221.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  12 in total

1.  A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group.

Authors:  V Biton; G D Montouris; F Ritter; J J Riviello; R Reife; P Lim; G Pledger
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

2.  Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures.

Authors:  V Biton; J C Sackellares; A Vuong; A E Hammer; P S Barrett; J A Messenheimer
Journal:  Neurology       Date:  2005-12-13       Impact factor: 9.910

Review 3.  Zonisamide for absence seizures.

Authors:  Angus Wilfong; Rebecca Schultz
Journal:  Epilepsy Res       Date:  2005-04-19       Impact factor: 3.045

4.  Lamictal (lamotrigine) monotherapy for typical absence seizures in children.

Authors:  L M Frank; T Enlow; G L Holmes; P Manasco; S Concannon; C Chen; G Womble; E J Casale
Journal:  Epilepsia       Date:  1999-07       Impact factor: 5.864

5.  Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absence.

Authors:  Jennifer Cavitt; Michael Privitera
Journal:  Arch Neurol       Date:  2004-10

6.  Levetiracetam treatment of idiopathic generalised epilepsy.

Authors:  Gregory L Krauss; Tim Betts; Bassel Abou-Khalil; Gregory Gergey; Helen Yarrow; Akemi Miller
Journal:  Seizure       Date:  2003-12       Impact factor: 3.184

7.  Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.

Authors:  Avinash Prasad; Ruben I Kuzniecky; Robert C Knowlton; Tim E Welty; Roy C Martin; M Mendez; Raymond E Faught
Journal:  Arch Neurol       Date:  2003-08

8.  Levetiracetam monotherapy in juvenile myoclonic epilepsy.

Authors:  Deron V Sharpe; Anup D Patel; Bassel Abou-Khalil; Gerald M Fenichel
Journal:  Seizure       Date:  2007-08-09       Impact factor: 3.184

9.  Is the underlying cause of epilepsy a major prognostic factor for recurrence?

Authors:  F Semah; M C Picot; C Adam; D Broglin; A Arzimanoglou; B Bazin; D Cavalcanti; M Baulac
Journal:  Neurology       Date:  1998-11       Impact factor: 9.910

10.  The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.

Authors:  Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.